5LB Prognostic value of autoantibodies in melanoma stage III patients in the EORTC 18991 phase III randomized trial comparing adjuvant pegylated interferon α2b vs observation

M.G.Bouwhuis; S.Suciu; A.Testori; M.Santinami; W.H.Kruit; C.J.Punt; F.Sales; P.M.Patel; A.Spatz; A.M.M.Eggermont

首页> 外文期刊>European Journal of Cancer Supplements >5LB Prognostic value of autoantibodies in melanoma stage III patients in the EORTC 18991 phase III randomized trial comparing adjuvant pegylated interferon α2b vs observation

【24h】

5LB Prognostic value of autoantibodies in melanoma stage III patients in the EORTC 18991 phase III randomized trial comparing adjuvant pegylated interferon α2b vs observation

机译：5LB EORTC 18991 III期随机试验比较聚乙二醇干扰素α2b与观察性辅助疗法对黑色素三期患者自身抗体的预后价值

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2007年第6期|共2页
作者
M.G.Bouwhuis; S.Suciu; A.Testori; M.Santinami; W.H.Kruit; C.J.Punt; F.Sales; P.M.Patel; A.Spatz; A.M.M.Eggermont;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Prognostic value of autoantibodies in melanoma stage III patients in the EORTC 18991 phase III randomized trial comparing adjuvant pegylated interferon a2b vs observation [J] . M.G. Bouwhuis, S. Suciu, A. Testori, European Journal of Cancer Supplements . 2007,第6期

机译：比较聚乙二醇干扰素a2b与佐剂的对比试验在EORTC 18991 III期随机试验中对Ⅲ期黑色素瘤患者自身抗体的预后价值。
2. Serum concentrations of pegylated interferon α-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon α-2b in a randomized phase III trial (EORTC 18991) [J] . Alexander M. M. Eggermont, Marna G. Bouwhuis, Wim H. Kruit, Cancer Chemotherapy and Pharmacology . 2010,第4期

机译：在一项随机化的III期临床试验中，接受了聚乙二醇化干扰素α-2b辅助治疗的切除的III期黑色素瘤患者中的聚乙二醇化干扰素α-2b的血清浓度（EORTC 18991）
3. Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991). [J] . Eggermont AM, Bouwhuis MG, Kruit WH, Cancer chemotherapy and pharmacology. . 2010,第4期

机译：在一项随机III期试验（EORTC 18991）中，接受了聚乙二醇化干扰素α-2b辅助治疗的切除III期黑色素瘤患者的聚乙二醇化干扰素α-2b的血清浓度。
4. A comparison of methods for estimating survival probabilities in two stage phase III randomized clinical trials. [D] . Wang, Ying. 2009

机译：在两个阶段的III期随机临床试验中比较评估生存概率的方法。
5. Phase III trial (EORTC 18071 / CA184-029) of post-operative adjuvant ipilimumab compared to placebo in patients with resected stage III cutaneous melanoma: Health Related Quality of Life (HRQoL) results [O] . Corneel Coens, Stefan Suciu, Vanna Chiarion-Sileni, -1

机译：Ⅲ期皮肤黑色素瘤切除术后患者与安慰剂比较伊普利姆单抗术后Ⅲ期试验（EORTC 18071 / CA184-029）：健康相关生活质量（HRQoL）结果
6. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial [O] . Eggermont, A M M, Suciu, S, Santinami, M, 2008

机译：聚乙二醇干扰素α-2b的辅助治疗与单独治疗III期黑色素瘤的观察：EORTC 18991的最终结果（一项随机III期试验）

5LB Prognostic value of autoantibodies in melanoma stage III patients in the EORTC 18991 phase III randomized trial comparing adjuvant pegylated interferon α2b vs observation

著录项

相似文献

相关主题

期刊订阅